Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Tariffs

Medtech is Essential: Industry Supports Call for Tariff Flexibility 

AdvaMed President and CEO Scott Whitaker testified before the U.S. Senate Finance Committee, bringing attention to the pressing issue of how tariffs could impact the medtech industry and, most importantly,…

Government & Legislative Affairs / Regulatory Affairs

Orthogonal, Kwame Ulmer on the Value of AdvaMed Membership

At AdvaMed, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame…

Coverage & Payment / Government & Legislative Affairs / Regulatory Affairs

AdvaMed Congratulates Dr. Oz on his Confirmation as CMS Administrator 

Washington, D.C.– AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Mehmet Oz to serve as Administrator of…

Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Small Business

AdvaMed®’s Medical Innovation Agenda for the 119th Congress

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.

Online

Richardson Waiver Repeal: What it Means for Medtech

Sidley Austin, joined by HPA, will lead a program examining the impact of HHS repealing the so-called “Richardson Waiver”, including its history, how it could impact the activities of the…

Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Health Equity / Legal / Regulatory Affairs / Small Business

The Medical Innovation Agenda for the 119th Congress

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.